Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-24 @ 10:14 PM
NCT ID:
NCT04362735
Eligibility Criteria:
Inclusion Criteria:
\- Patients with CD (any location)who used vedolizumab as the first biological agent during medical treatment, after failure of conventional therapy (5-ASA, steroids and/or immunomodulators such as azathioprine and methotrexate).
Exclusion Criteria:
* Patients with UC
* Patients with other causes of intestinal inflammation (ischemic or infectious colitis, for example) non-IBD related
* Patients with IBD-undetermined not defined as CD or UC
* Patients with vedolizumab who had previous exposure to anti-TNF agents
* Pregnant patients
* Pediatric patients (less than 18 years old)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04362735
Study Brief:
Protocol Section:
NCT04362735